Passengers should be advised to wear masks in high-risk settings...
Category:
Health
Latest
Shortage of healthcare workers globally may rise to 10 mn by decade-end: WEF study
Launched in the run-up to the World Economic Forum (WEF) Annual...
National Health Authority introduces new system to measure performance of hospitals under Ayushman Bharat PM-JAY
RS Sharma, CEO, National Health Authority The statement said that...
“Arogya Sanjeevani”policy can be offered as a group cover:IRDAI
The group policy is expected to provide protection to a large number of employees engaged in manufacturing, services, SMEs, MSMEs,logistics sector and migrant workers, catering to their medical needs, said IRDAI
Cipla gets India approval to sell COVID-19 drug favipiravir
Indian drugmakers including Glenmark Pharmaceuticals Ltd are racing to supply generic versions of favipiravir, originally developed by Japan’s Fujifilm Holdings Corp as Avigan for treating influenza.
Scavengers in India risk health to sift coronavirus debris
Dinesh Raj Bandela, an expert in biomedical waste at the Delhi-based think tank Centre for Science and Environment, said protocols for disposal of biomedical waste were not necessarily being followed during the outbreak, putting those who sift through landfills at risk.
About 400,000 global airline jobs lost or at risk due to virus
Job losses in related industries including aircraft manufacturers, engine makers, airports and travel agencies could reach 25 million, according to the International Air Transport Association. The hotels and lodging sector in the U.S. sees 7.5 jobs lost for every one in aviation. Airbus SE and Boeing Co. are cutting more than 30,000 positions.
WHO chief scientist sees no herd immunity to Covid-19 yet
As there are waves of this infection going through countries, people are going to develop antibodies and those people will hopefully be immune for sometime so they will also act as barriers and brakes to the spread.” Other experts have estimated that as much as 70% to 80% of the population need to have antibodies before there is any herd immunity effect.
India has one of world’s lowest Covid infection & death rate, says Harsh Vardhan
He explained that a series of actions were initiated in a graded way that included issuing of travel advisories, point-of-entry surveillance, community-based surveillance, enhancement of laboratory and hospital surge capacities, wide dissemination of technical guidelines on managing different aspects of disease outbreak and communicating risk to the public.
WHO reports record daily increase in global coronavirus cases, up over 284,000
The WHO reported 69,641 new cases in the United States, 67,860 in Brazil, 49,310 in India and 13,104 in South Africa. The largest increases in new deaths were 3,876 in Peru, 1,284 in Brazil, 1,074 in the United States, 790 in Mexico and 740 in India.
Covid-19 Pandemic:Record 45,720 new cases,deaths rise by 1,129,tally crosses 12-lakh mark in India
The coronavirus caseload in the country surged to12,38,635,while 7,82,606 people have recovered so far in the country,the data updated at 8 am showed
Of the 1,129 deaths reported in the last 24 hours, 18 are from Tamil Nadu, 280 from Maharashtra, 65 from Andhra Pradesh,?55 from Karnataka, 39 from West Bengal, 34 from Uttar Pradesh, 29 from Delhi, 28 from Gujarat, 14 from Madhya Pradesh and 10 from Jammu and Kashmir
India Covid recovery rate at 63% after record 28,472 recuperations in a day
States and Union Territories with recovery rate higher than the national average include Delhi (84.83 pc), Telangana (78.37 pc), Rajasthan (72.50 pc), Gujarat (72.30 pc), Chhattisgarh (71.81 pc), Assam (71.05 pc), Odisha (70.96 pc), Tamil Nadu (70.12 pc), Madhya Pradesh (67.47 pc) and Bihar (63.95).
According to the Indian Council of Medical Research (ICMR), a total of 1,47,24,546 samples have been tested up to July 21 with 3,43,243 samples being tested on Tuesday.
Swiss Re books $476 million of Covid-19 losses in March quarter
A range of factors relating to the pandemic,including future infection and mortality rates;the duration and effects of mitigation measures, including on business activity; the timing of an effective vaccine and/or alternative treatment solutions; legislative or regulatory efforts and the outcome of court and arbitration cases on coverage issues; the impact of government stimulus packages;and the severity and duration of recessionary impacts,may impact claims development in the coming quarters, either positively or negatively,relative to Swiss Re’s projections.